主页 > 生命科学 >
【bio-news--快讯】可望从干细胞中产生胰岛素，欢
Last updated: Monday, October 23, 2006
A process to turn human embryonic stem cells into pancreatic stem cells able to produce insulin and other hormones has been developed by the California biotechnology company Novocell.
The research was published online Thursday by the journal Nature Biotechnology.
This represents an advance in efforts to use embryonic stem cells to replace the insulin-producing cells that are destroyed by the immune system in people with type 1 diabetes, The New York Times reported.
However, scientists still need to conduct years of research before this approach may lead to a therapy for people with type 1 diabetes, the newspaper said.
"The study provides some very strong evidence that it will be possible to make insulin-producing pancreatic beta cells from human E.S. (embryonic stem) cells in a culture dish," Dr Mark A. Magnuson, a professor at Vanderbilt University, wrote in an e-mail message to the Times.
The Novocell team achieved an efficiency of cell conversion and insulin production in "orders of magnitude higher than anything previously accomplished," Magnuson said. ?(HealthDayNews 认领先。。。 Insulin from stem cells?
从干细胞获得胰岛素？
Last updated: Monday, October 23, 2006
A process to turn human embryonic stem cells into pancreatic stem cells able to produce insulin and other hormones has been developed by the California biotechnology company Novocell.
将人类胚胎干细胞转换成胰脏干细胞，其能分泌胰岛素及其它激素，此技术过程已经由加利福尼亚生物技术公司Novocell完成。
The research was published online Thursday by the journal Nature Biotechnology.
研究发表在本周四的自然生物技术学杂志。
This represents an advance in efforts to use embryonic stem cells to replace the insulin-producing cells that are destroyed by the immune system in people with type 1 diabetes, The New York Times reported.
本研究在用胚胎干细胞代替Ⅰ型糖尿病患者体内被免疫系统摧毁的胰岛素分泌细胞方面是一个进步，纽约时报报道。
However, scientists still need to conduct years of research before this approach may lead to a therapy for people with type 1 diabetes, the newspaper said.
然而，报纸上说，将此方法用于Ⅰ型糖尿病患者的治疗，科学家还需要进行多年的研究。
"The study provides some very strong evidence that it will be possible to make insulin-producing pancreatic beta cells from human E.S. (embryonic stem) cells in a culture dish," Dr Mark A. Magnuson, a professor at Vanderbilt University, wrote in an e-mail message to the Times.
“此研究为在培养皿中把人类胚胎干细胞诱导成胰岛β细胞（可分泌胰岛素）提供了有力证据。” Vanderbilt 大学教授、Mark A. Magnuson博士在写给纽约时报的电子邮件中提到。
The Novocell team achieved an efficiency of cell conversion and insulin production in "orders of magnitude higher than anything previously accomplished," Magnuson said. ?(HealthDayNews
Magnuson 说，Novocell公司的研究小组完成了一个有效的细胞转换过程，使胰岛素能以前所未有的数量产生。（每日健康新闻） 从干细胞获得胰岛素？
将人类胚胎干细胞转换成胰脏干细胞，其能分泌胰岛素及其它激素，此技术过程已经由加利福尼亚生物技术公司Novocell完成。
研究发表在本周四的自然生物技术学杂志。
本研究在用胚胎干细胞代替Ⅰ型糖尿病患者体内被免疫系统摧毁的胰岛素分泌细胞方面是一个进步，纽约时报报道。
然而，报纸上说，科学家还需要进行多年的研究才能将此方法用于Ⅰ型糖尿病患者的治疗。
“此研究为在培养皿中把人类胚胎干细胞诱导成胰岛β细胞（可分泌胰岛素）提供了有力证据。” Vanderbilt 大学教授、Mark A. Magnuson博士在写给纽约时报的电子邮件中提到。
Magnuson 说，Novocell公司的研究小组完成了一个有效的细胞转换过程，使胰岛素能以前所未有的数量产生。（每日健康新闻） http://www.dxy.cn/bbs/post/view?bid=116&id=7313151&sty=1&tpg=7&age=0 [标签:content1][标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-06-28 05:45
医学,生命科学网